Skip to main content
. Author manuscript; available in PMC: 2008 Nov 1.
Published in final edited form as: J Pain. 2007 Jul 23;8(11):850–860. doi: 10.1016/j.jpain.2007.05.015

Figure 4.

Figure 4

Effects of O-1691 on improgan (A) or WIN 55,212−2 (B) antinociception in rats. Subjects were treated and tested as in Fig. 3, except O-1691 was injected instead of rimonabant. The same DMSO/DMSO, DMSO/Imp, and DMSO/WIN data are shown in Fig. 3. Footnotes indicating statistical significances are the same as in Fig. 3.